Arteriosclerosis hardening of the arteries Serum cholesterol above
Fibrate - YouTube
Anticancer Properties of Fenofibrate: A Repurposing Use
Lipid modifying drug dr. tariqul
Mechanism of action of fi brates. Abbreviations: HDL, high-density... | Download Scientific Diagram
Pharmacology of Fibric Acid Derivatives - BioPharma Notes
List of fibrates: Uses, common brands, and safety information
The Role of Fibrates in Primary Biliary Cholangitis | SpringerLink
Myopathy with statin–fibrate combination therapy: clinical considerations | Nature Reviews Endocrinology
Proposed dual mechanism for fibrate mediated repression of PCSK9 to... | Download Scientific Diagram
Mechanism of antiplatelet action of hypolipidemic, antidiabetic and antihypertensive drugs by PPAR activation: PPAR agonists: new antiplatelet agents. | Semantic Scholar
Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis - The Lancet
Fibrate - Wikipedia
Pemafibrate, a New Selective PPARα Modulator: Drug Concept and Its Clinical Applications for Dyslipidemia and Metabolic Diseases | SpringerLink
Clinical Applications of a Novel Selective PPARα Modulator, Pemafibrate, in Dyslipidemia and Metabolic Diseases. - Abstract - Europe PMC
Fibrates
Is There a Role for Fibrates in the Management of Dyslipidemia in the Metabolic Syndrome? | Arteriosclerosis, Thrombosis, and Vascular Biology
MedSeptic - Fibrate:- In pharmacology, the fibrates are a class of amphipathic carboxylic acids. They are used for a range of metabolic disorders, mainly hypercholesterolemia (high cholesterol), and are therefore hypolipidemic agents. . . . . #
Triglyceride Lowering Drugs - Endotext - NCBI Bookshelf
Dyslipidemia case study
Ciprofibrate - an overview | ScienceDirect Topics
Fenofibrate in cancer: mechanisms involved in... | F1000Research
Update on the use of fibrates: focus on bezafibrate. - Abstract - Europe PMC
Pemafibrate, a New Selective PPARα Modulator: Drug Concept and Its Clinical Applications for Dyslipidemia and Metabolic Diseases | SpringerLink
Fibrate pharmacogenomics: expanding past the genome | Pharmacogenomics
